Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors - Test2 - elhamkhani - TriplyDB

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors

http://www.wikidata.org/entity/Q28069632

about

Disease Control on Lanreotide Autogel® 120 mg in a Patient with Metastatic Gastrinoma: A Case Report.Carcinoid-syndrome: recent advances, current status and controversies.Novel Somatostatin Receptor Ligands Therapies for Acromegaly.

P2860

Q50048308-F12C786A-C243-44AB-97AA-92227DB54AA9 Q50094023-0E81DA6B-B6D4-4E9E-B1C0-5FEE90E0F8C0 Q52643700-D1E72F76-1590-4A3A-891B-D30CA6BAD092

P2860

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors

http://www.wikidata.org/entity/Q28069632

description

2016 nî lūn-bûn

@nan

2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors

@ast

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors

@en

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors

@nl

type

label

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors

@ast

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors

@en

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors

@nl

altLabel

Clinical utility of lanreotide Autogel(®) in gastroenteropancreatic neuroendocrine tumors

@en

prefLabel

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors

@ast

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors

@en

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors

@nl

P1433

Q28069632-5949A9F0-DFFC-424B-BDF9-CBCF1FF2E93A

P1476

Q28069632-073B1BB8-F4FF-4D96-8651-5D93258FB874

P2093

Q28069632-2751B0BB-A599-4761-AACA-C3A4302F96B4

Q28069632-3FD70E05-F905-442B-8287-A2EAD29C8525

Q28069632-7D56B1EB-43C6-4A20-A9B3-428B3E12D9D0

Q28069632-8ED741C3-2217-4934-AAA0-DFDC7FD36752

Q28069632-920A580A-C3D1-4716-993B-68BF7E030FB9

Q28069632-B51759D1-7368-45D5-BAD3-4CC26B202685

Q28069632-E4882E32-8916-42A3-B1D0-75535F03F271

P275

Q28069632-6513932B-3AA4-4AEC-8888-7B41B8343030

P2860

Q28069632-021C7A2C-1230-4019-8BFA-7219A897762B

Q28069632-0247788E-2B53-4C41-BD8E-4EE9D2A038F1

Q28069632-0A25A619-AF3D-41F0-93CC-1E2A9F7D931B

Q28069632-1518BB52-E600-4E2E-BCA6-A8F9B594E8A5

Q28069632-2134C743-1CD5-412D-8165-43E03F2B9085

Q28069632-28311AE6-2832-4911-A9FF-6F058AABE5A4

Q28069632-2BE367E6-9737-4F44-9F65-06A4C27A94C8

Q28069632-2C39CC2B-26EA-4C5E-9E44-D1CFF3001688

Q28069632-2F58DA64-A0B9-4D85-ADD5-99A06AE4D92C

Q28069632-4416A551-2DB0-4AED-BB1A-AB5B04C0391E

P304

Q28069632-3505F69E-8741-40BB-A2CC-C96CB5926BAC

P31

Q28069632-8EDCCECE-F201-452B-B0FD-371FFA434F62

Q28069632-C03F8F4A-C116-4CC4-A33F-463EFB17FB8F

P3181

Q28069632-2BECCD94-87FB-4AAF-AE8F-DD51170A14C7

P356

Q28069632-27DD2814-03CE-412E-9D36-35A5EB02084B

P407

Q28069632-296F0E12-4203-4F2E-847D-7DE0B0D77E2C

P478

Q28069632-A7851653-DCDE-4D13-97F5-811F67DB84B8

P5008

Q28069632-B94D6D16-EAF4-4BD7-AE6E-AA81F05B6149

P577

Q28069632-D2B57EB7-DE1A-4FED-A0C3-D969AC1F60D7

P698

Q28069632-D0610875-B33A-4901-924A-4D08F087168A

P921

Q28069632-26AF6768-C28F-46A8-B55D-6DD1DC507E2B

Q28069632-2CD4D4E8-EA72-4728-9C72-2C05A9B672E6

Q28069632-60E6A1E9-F26D-475B-A11D-069F7D4DC9B9

Q28069632-67260495-C4CD-434F-90A7-7823F2AE7185

Q28069632-815021C3-A84A-4E07-AD19-620F13F08E69

Q28069632-85CE276B-73A8-4156-BD61-503E44D0352A

Q28069632-953A391B-8D78-4255-8918-9A91AD06A559

Q28069632-B35DC5F1-A5AD-4062-8FE1-1CCF7D2A231D

Q28069632-B764984E-F080-4F5B-9DEE-07D16B92B670

Q28069632-DAA142A2-3594-4F51-964A-15DAEE5EA86D

P932

Q28069632-5789161E-0223-46F7-A526-0B7DF72A19BD

P3181

P356

P1433

Drug Design, Development and Therapy

P1476

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors

@en

P2093

Alessandro Prete

http://www.w3.org/2001/XMLSchema#string

Alfredo Pontecorvi

http://www.w3.org/2001/XMLSchema#string

Andrea Corsello

http://www.w3.org/2001/XMLSchema#string

Francesco Torino

http://www.w3.org/2001/XMLSchema#string

Giampaolo Papi

http://www.w3.org/2001/XMLSchema#string

Rosa Maria Paragliola

http://www.w3.org/2001/XMLSchema#string

Salvatore Maria Corsello

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Advances in the pharmacotherapy of patients with acromegaly

Somatostatin and its receptor family

Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis

Lanreotide in metastatic enteropancreatic neuroendocrine tumors

Rationale for the use of somatostatin analogs as antitumor agents

Neuroendocrine tumors of the gastro-entero-pancreatic system

Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.

Antiproliferative effect of somatostatin and analogs.

Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.

The role of somatostatin and its analogs in the diagnosis and treatment of tumors.

P304

3459-3470

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2812180

http://www.w3.org/2001/XMLSchema#string

P356

10.2147/DDDT.S76732

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2016-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27822010

http://www.w3.org/2001/XMLSchema#string

P921

stomach neoplasm

intestinal cancer

neuroendocrine tumor

pancreatic cancer

polycyclic compound

intestinal neoplasm

P932

5087808

http://www.w3.org/2001/XMLSchema#string